EICHOR
● Recruiting
Clinical Pre-screening Protocol for Ovarian Cancer
Condition: Ovarian Cancer · Sponsor: Allarity Therapeutics
About this study
The patient's local archival tumor tissue (FFPE) from original tumor, or from the metastatic tissue, will be collected to potentially identify if they - at a later stage of their disease - will be likely to benefit from treatment with any of the investigational cancer drugs available to Allarity Therapeutics. Data from this study can further be used to explore in a retrospective fashion, sensitivity to other chemotherapeutic drugs previously used in the treatment of their ovarian cancer, to investigate whether or not the DRP® method can predict and confirm the obtained sensitivity to the prior given drugs as well as prospective analyses guiding the Investigators on future treatments.
This description comes directly from the study's public registry record.
Talk to the study team
US: Kathleen Moore · +1 405-271-8707 · KathleenMoore@ouhealth.com
Europe: Rebecca Kristeleit · Rebecca.Kristeleit@gstt.nhs.uk
Always discuss trial participation with your own doctor first.
Locations (9)
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Emory Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| University of New Mexico Comprehensive Cancer | Albuquerque, New Mexico, United States | Recruiting |
| The Blavatnik Family-Chelsea Medical Center at Mount Sinai | New York, New York, United States | Recruiting |
| OU Health Stephenson Cancer Center | Oklahoma City, Oklahoma, United States | Recruiting |
| University Medical Center Cancer Center | Lubbock, Texas, United States | Recruiting |
| Swedish Center for Research and Innovation | Seattle, Washington, United States | Recruiting |
| Beatson West of Scotland Cancer Centre | Glasgow, Scotland, United Kingdom | Recruiting |
| Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital | London, United Kingdom | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03877796